A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

BACKGROUND: We sought to compare the benefits and safety of 6 biologics (abatacept, adalimumab, anakinra, etanercept, infliximab and rituximab) in patients with rheumatoid arthritis. METHODS: In this network meta-analysis, we included all completed and updated Cochrane reviews on biologics for rheum...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Singh, Jasvinder A., Christensen, Robin, Wells, George A., Suarez-Almazor, Maria E., Buchbinder, Rachelle, Lopez-Olivo, Maria Angeles, Ghogomu, Elizabeth Tanjong, Tugwell, Peter
Format: Artigo
Jezik:Inglês
Izdano: Canadian Medical Association 2009
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2780484/
https://ncbi.nlm.nih.gov/pubmed/19884297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.091391
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items